Evidence map›Paper›PMID 28526090›Full record

ArticleRespiratory research2017

Reduced HDAC2 in skeletal muscle of COPD patients.

Masako To, Elisabeth B Swallow, Kenich Akashi, Kosuke Haruki, S Amanda Natanek, Michael I Polkey, Kazuhiro Ito, Peter J Barnes

Open access · goldAbstract read
In one paragraph

Article in Respiratory research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it, 29 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. The role and mechanism of histone deacetylase in COPD.Molecular and cellular biochemistry · 2026
    Review
  5. Article
  6. Review
  7. Article
  8. Epigenetic regulation of pulmonary inflammation.Seminars in cell & developmental biology · 2024
    Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Review
  18. Histone Lys demethylase KDM3C demonstrates anti-inflammatory effects by suppressing NF-κB signaling and osteoclastogenesis.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2019
    Article
  19. Genetic ablation of histone deacetylase 2 leads to lung cellular senescence and lymphoid follicle formation in COPD/emphysema.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2018
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 3 countries.

Masako ToAirway Disease Section, National Heart and Lung Institute, Imperial College, Dovehouse Street, London, SW3 6LY, UK.
Elisabeth B SwallowNIHR Respiratory Biomedical Research Unit at the Royal Brompton and Harefield Foundation Trust & Imperial College, London, UK.
Kenich AkashiAirway Disease Section, National Heart and Lung Institute, Imperial College, Dovehouse Street, London, SW3 6LY, UK.
Kosuke HarukiDepartment of Laboratory Medicine, Dokkyo Medical University Koshigaya Hospital, 2-1-50 Minami-Koshigaya, Koshigaya-City, Saitama, 343-8555, Japan.
S Amanda NatanekNIHR Respiratory Biomedical Research Unit at the Royal Brompton and Harefield Foundation Trust & Imperial College, London, UK.
Michael I PolkeyNIHR Respiratory Biomedical Research Unit at the Royal Brompton and Harefield Foundation Trust & Imperial College, London, UK.
Kazuhiro ItoAirway Disease Section, National Heart and Lung Institute, Imperial College, Dovehouse Street, London, SW3 6LY, UK.
Peter J BarnesAirway Disease Section, National Heart and Lung Institute, Imperial College, Dovehouse Street, London, SW3 6LY, UK. p.j.barnes@imperial.ac.uk.
Imperial College London · GBRoyal Brompton & Harefield NHS Foundation Trust · GBDokkyo Medical University Saitama Medical Center · JP

Funding

Wellcome TrustWellcome Trust 076472/Z/05/Z
6 · The paper itself

Abstract

backgroundSkeletal muscle weakness in chronic obstructive pulmonary disease (COPD) is an important predictor of poor prognosis, but the molecular mechanisms of muscle weakness in COPD have not been fully elucidated. The aim of this study was to investigate the role of histone deacetylases(HDAC) in skeletal muscle weakness in COPD. METHODS AND

resultsTwelve COPD patients, 8 smokers without COPD (SM) and 4 healthy non-smokers (NS) were recruited to the study. HDAC2 protein expression in quadriceps muscle biopsies of COPD patients (HDAC2/β-actin: 0.59 ± 0.34) was significantly lower than that in SM (1.9 ± 1.1, p = 0.0007) and NS (1.2 ± 0.7, p = 0.029). HDAC2 protein in skeletal muscle was significantly correlated with forced expiratory volume in 1 s % predicted (FEV

conclusionSkeletal muscle weakness in COPD may result from HDAC2 down-regulation in skeletal muscle via acetylation and activation of NF-κB. The restoration of HDAC2 levels might be a therapeutic target for improving skeletal muscle weakness in COPD.

Indexed as

AgedFemaleHistone Deacetylase 2HumansMaleMiddle AgedMuscle, SkeletalMuscle WeaknessNF-kappa BPulmonary Disease, Chronic ObstructiveHDAC2 protein, humanHistone Deacetylase 2NF-kappa BApoptosisCOPDHDAC2Nuclear factor-kappa BSkeletal muscle dysfunction

Identifiers

PMID28526090
PMCPMC5438490
OpenAlexW2616123180

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.